Advanced Search
Lu Yi-Yong, et al, . The Effecacy of Domperidone as a Preventing Emetic Agnet in Chemotherapy-Induced Emeses[J]. Cancer Research on Prevention and Treatment, 1996, 23(4): 242-244.
Citation: Lu Yi-Yong, et al, . The Effecacy of Domperidone as a Preventing Emetic Agnet in Chemotherapy-Induced Emeses[J]. Cancer Research on Prevention and Treatment, 1996, 23(4): 242-244.
shu

The Effecacy of Domperidone as a Preventing Emetic Agnet in Chemotherapy-Induced Emeses

  • Jiangsu Cancer Institute and Hospital.Department of Medical Oncology, 210009.

More Information
    Graphical Abstract
    • Abstract
  • Domperidone is a dopamin receptor blocker which is few adverses. Domperidone is admited by oral loaded dose and following by sublingual sustaining dose to prevert chemotherapy-induced emeses. The complete control rate of emese is 74.3% in containing MD-cisplatin regimens, 81.8% in containing middle-induced emeses agents and ondansetron is 74.0% in containgin MD-cisplatin regimens.Domperidone is not significant adverses and its expanse is much low.
    • FullText(HTML)
    • References (4)
  • 1 关于核仁组成区研究工作的标准化方案.中华肿瘤杂志，1993, 15(5):380.
    2 Hwang WS, Chen LM, Huang S> et al. Prediction of chemotherapy response in human leukemia using in vitro chemosensitivity test. leukemia research,1993, 17 ;685.
    3 张绍林，席雨人.急性白血病化疗药物体外敏感性MTT法的研究.中华血液学杂志，1990, 11:16.
    4 殷建林，等.58例白血病综合药敏试验的前眩性研究.临床血液学杂志，1991，4(2):58.
    • Related Articles

  • Related Articles

    [1]CHENG Xiaowei, WANG Chunlin, HUANG Xiaoqing, ZHANG Yong. VEGF Gene Promoter Region-460 T/C Single Nucleotide Polymorphisms and Nasopharyngeal Carcinoma Susceptibility in Guangxi Population[J]. Cancer Research on Prevention and Treatment, 2014, 41(10): 1125-1128. DOI: 10.3971/j.issn.1000-8578.2014.10.015
    [2]ZHANG Fengqi, SHEN Yan, WANG Shanshan, WEI Xiao. Significance of TYMS and ERCC1 Gene Polymorphism in Peripheral Venous Blood in Evaluating the Chemotherapeutic Effect on Patients with Gastroenteric Tumor Patients[J]. Cancer Research on Prevention and Treatment, 2014, 41(08): 906-911. DOI: 10.3971/j.issn.1000-8578.2014.08.011
    [3]Tang Li, Zhang Weihong, Fan Hongping, Zhu Xiao. Association between Polymorphism of Heat-shock Protein A5 and HBV Invasion[J]. Cancer Research on Prevention and Treatment, 2012, 39(06): 680-682. DOI: 10.3971/j.issn.1000-8578.2012.06.016
    [4]Zhang Lan, Li Shengmian, Zhang Huijing, Wu Yijuan. Expression of CD34,8-OHdG and Ki67 in Patients with HBV-HCC and Their Significances to Prognosis of HCC[J]. Cancer Research on Prevention and Treatment, 2012, 39(05): 547-550. DOI: 10.3971/j.issn.1000-8578.2012.05.013
    [5]Bai Hua, Qiu Xiaoqiang, Liu Shun, Bei Chunhua, Zeng Xiaoyun, Yu Hongping. Study on Susceptibility of HBV Infection and Primary Hepatocellular Carcinoma with Gene Polymorphism of IFN-gamma[J]. Cancer Research on Prevention and Treatment, 2012, 39(03): 329-334. DOI: 10.3971/j.issn.1000-8578.2012.03.021
    [6]ZHANG Xiao-mei, BIN Liang-hua, WANG Jie-ru, SHEN Shuo-rong, LI Gui-yuan. Expression of Tumor Related Gene NAG6 in Gastric Cancer and RFLP Analysis[J]. Cancer Research on Prevention and Treatment, 2006, 33(04): 231-234. DOI: 10.3971/j.issn.1000-8578.3390
    [7]ZHAO Hong, LI Xiao-long, FAN Xia, et al, . The relationship of primary liver carcinoma and hepatitis B virus infection in the north region of Shanxi province[J]. Cancer Research on Prevention and Treatment, 2002, 29(02): 147-149. DOI: 10.3971/j.issn.1000-8578.1684
    [8]CHEN Dao-guang, HUANG Xue-zhen. Study on the Relationship between Hepatitis Virus(HBV) and Liver Damage in Chemotherapy of Lymphoma[J]. Cancer Research on Prevention and Treatment, 1999, 26(4): 268-269.
    [9]Yang Tingtong, . The Study of P53 Gene Mutation in Human Small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 1998, 25(6): 445-447.

Catalog

    Get Citation
    PDF
    XML
    Article views (1213) PDF downloads (260) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Download Center

    Links

    Contact Us

    Address：116 Zhuodaoquan South Road,
    Hongshan District, Wuhan（430079）

    Tel：027－87670126

    Email：zlfzyjzz@vip.163.com

    This work is licensed under a Creative Commons Attribution 3.0 License.

    Email Alert RSS
    Total visits：12169033 Visits today：27306

    Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return